140 related articles for article (PubMed ID: 30885040)
1. Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
Brooks JP; Azmy V; Thompson A; Luon D; Prozora SD; Price C; Hsu FI
J Oncol Pharm Pract; 2020 Jan; 26(1):228-231. PubMed ID: 30885040
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
Collier K; Schink C; Young AM; How K; Seckl M; Savage P
J Oncol Pharm Pract; 2008 Mar; 14(1):51-5. PubMed ID: 18337441
[TBL] [Abstract][Full Text] [Related]
3. Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide.
Siderov J; Prasad P; De Boer R; Desai J
Br J Cancer; 2002 Jan; 86(1):12-3. PubMed ID: 11857004
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitivity reactions to etoposide phosphate.
Sambasivan K; Mahmoud S; Kokache A; Seckl M; Savage P
J Oncol Pharm Pract; 2014 Apr; 20(2):158-60. PubMed ID: 23740378
[TBL] [Abstract][Full Text] [Related]
5. Etoposide and etoposide phosphate hypersensitivity in children: Incidence, risk factors, and prevention strategies.
Stockton WM; Nguyen T; Zhang L; Dowling TC
J Oncol Pharm Pract; 2020 Mar; 26(2):397-405. PubMed ID: 31315549
[TBL] [Abstract][Full Text] [Related]
6. Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide.
Bernstein BJ; Troner MB
Pharmacotherapy; 1999 Aug; 19(8):989-91. PubMed ID: 10453971
[TBL] [Abstract][Full Text] [Related]
7. Successful Treatment with Etoposide Base after an Acute Hypersensitivity Reaction to Etoposide Phosphate.
Leguay Z; Bourneau-Martin D; Pellier I; Le Louet H; Drablier G; Lagarce L; Lainé-Cessac P
Pediatr Blood Cancer; 2016 Mar; 63(3):571. PubMed ID: 26468691
[No Abstract] [Full Text] [Related]
8. [Hypersensitivity reaction to etoposide. A case report].
Mullera Martí M; Riba Solé M; Fernández de Gamarra Martínez E; Mangues Bafalluy MA
Farm Hosp; 2014 May; 38(3):255-6. PubMed ID: 24951914
[TBL] [Abstract][Full Text] [Related]
9. Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.
Pringle NR; Gilbar PJ; Grewal GD
J Oncol Pharm Pract; 2022 Jun; 28(4):1019-1023. PubMed ID: 35037804
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies.
Hainsworth JD; Utley SM; Greco FA
Invest New Drugs; 1997; 15(4):325-9. PubMed ID: 9547675
[TBL] [Abstract][Full Text] [Related]
11. Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease.
Hudson MM; Weinstein HJ; Donaldson SS; Greenwald C; Kun L; Tarbell NJ; Humphrey WA; Rupp C; Marina NM; Wilimas J
J Clin Oncol; 1993 Jun; 11(6):1080-4. PubMed ID: 8501494
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of etoposide phosphate plus paclitaxel.
Brooks DJ; Alberts DS
Semin Oncol; 1996 Dec; 23(6 Suppl 13):30-3. PubMed ID: 8996573
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.
Schuetze SM
J Natl Compr Canc Netw; 2007 Apr; 5(4):449-55. PubMed ID: 17442235
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacokinetic study of etoposide phosphate.
Brooks DJ; Srinivas NR; Alberts DS; Thomas T; Igwemzie LM; McKinney LM; Randolph J; Schacter L; Kaul S; Barbhaiya RH
Anticancer Drugs; 1995 Oct; 6(5):637-44. PubMed ID: 8845473
[TBL] [Abstract][Full Text] [Related]
15. Particular cutaneous side effects with etoposide-containing courses: is VP16 or etoposide phosphate responsible?
Marigny K; Aubin F; Burgot G; Le Gall E; Gandemer V
Cancer Chemother Pharmacol; 2005 Mar; 55(3):244-50. PubMed ID: 15526203
[TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for osteosarcoma and Ewing sarcoma.
Meyers PA
Am Soc Clin Oncol Educ Book; 2015; ():e644-7. PubMed ID: 25993235
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
Guo W; Tang XD; Tang S; Yang Y
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(12):805-8. PubMed ID: 16889724
[TBL] [Abstract][Full Text] [Related]
18. Two cases of suspected immunologic-based hypersensitivity reactions to etoposide therapy.
Kasperek C; Black CD
Ann Pharmacother; 1992 Oct; 26(10):1227-30. PubMed ID: 1421643
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma.
Scott JR; Ward DA; Crews KR; Panetta JC; Navid F
Pediatr Blood Cancer; 2014 Feb; 61(2):373-5. PubMed ID: 23955991
[TBL] [Abstract][Full Text] [Related]
20. Etoposide phosphate hypersensitivity overcome using a desensitisation programme enabling optimal therapy for relapsed Hodgkin lymphoma.
Polistena P; Tran Q; Cirillo M; O'Sullivan M; Purtill D
Bone Marrow Transplant; 2017 Mar; 52(3):455-456. PubMed ID: 27797366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
